Walder Wyss with Alvotech in Ivers-Lee acquisition
Walder Wyss advised biotech company Alvotech throughout its acquisition of the Ivers-Lee Group (Ivers-Lee).
The parties
Luxembourg-based Alvotech is a globally active biotech company specialising in the development and manufacture of biosimilar medicines for patients worldwide.
Headquartered in Burgdorf, Switzerland, Ivers-Lee specialises in high-quality assembly and packaging services for the pharmaceutical sector.
The Walder Wyss team
Counsel Samuel Lieberherr (corporate/M&A, pictured) led the Walder Wyss team on the matter, working alongside counsel Stefan Walder (corporate/M&A), senior associate Letizia Schlegel (corporate/M&A), associates Marius Denoth (employment) and Valentin Freiermuth (banking & finance), managing associate Ursina Gremminger (tax) and associate Daniela Hottiger (tax).
